In Australia, blood for transfusion has a "use by" date of 42 days after collection. The actual age of blood given to patients depends on what is available at the time and the rate of usage. During the last decade, it has been reported that blood transfusion in patients admitted to intensive care was associated with an independent increase of mortality. Some research suggests that transfusion of fresher blood might help patients in the intensive care unit to reach a better recovery. This project will test whether patients who receive 'fresher' blood do better than patients who receive 'standard issue' blood.
Inclusion criteria •Patients hospitalised in ICU with an anticipated ICU stay of at least 24 hours, in whom the decision has been made by medical staff to transfuse at least one RBC unit. Exclusion criteria * Age younger than 18 * Previous RBC transfusion during the current hospital admission (including transfusion in another hospital for transferred patients) * Diagnosis of transplantation or hematologic diseases * Pregnancy * Cardiac surgery during the present hospital admission * Expected to die imminently (\<24hrs) * The treating physician believes it is not in the best interest of the patient to be randomised in this trial. * Known objection to the administration of human blood products * Participation in a competing study Primary outcome- 90 day mortality Secondary outcomes 1. 28 day mortality 2. Persistent Organ Dysfunction combined with death at 28 3. Days alive and free of mechanical ventilation at day 90 post randomisation 4. Day alive and free of renal replacement therapy at day 90 post randomisation 5. Blood stream infection in ICU (post randomisation) defined using the Center for Disease Control and Prevention/National Healthcare Safety Network criteria 6. Length of stay in ICU and in hospital post randomisation 7. Febrile non-haemolytic transfusion reactions 8. EQ-5D score at Day 90 post randomisation
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
4,994
Blood transfusion in ICU patients aged 18 and over.
The Alfred Hospital
Melbourne, Victoria, Australia
Lyell McEwin Hospital
Adelaide, Australia
Queen Elizabeth Hospital
Adelaide, Australia
Royal Adelaide Hospital
Adelaide, Australia
Albury Hospital
Albury, Australia
Bendigo Hospital
Mortality at Day 90
Mortality at Day 90
Time frame: 90 Day
Mortality at Day 28
Mortality at day 28
Time frame: 28 day
Persistent Organ Dysfunction Combined With Death Measured at Day 28
Persistent Organ Dysfunction combined with death measured at day 28
Time frame: day 28
Days Alive and Free of Mechanical Ventilation
Days alive and free of mechanical ventilation
Time frame: day 28
Day Alive and Free of Renal Replacement Therapy.
Day alive and free of renal replacement therapy.
Time frame: day 28
Blood Stream Infection in ICU (Post Randomisation)
Blood stream infection in ICU (post randomisation) Time Frame is in Days
Time frame: While in ICU-Median duration in ICU - short term storage group was 4.2 days (2.0 - 9.3), long term storage group was 4.2 days (1.9 - 9.4)
Length of Stay in ICU and in Hospital Post Randomisation (Days)
Median duration in ICU - short term storage group was 4.2 (2.0 - 9.3), long term storage group was 4.2 (1.9 - 9.4) Median duration in Hospital - short term storage group was 14.5 (7.4 - 27.5), long term storage group was 14.7 (7.4 - 28.3) In Days
Time frame: Median duration in ICU- short term storage group 4.2 Days (2.0 - 9.3), long term storage group 4.2 Days (1.9 - 9.4). Median duration in Hospital- short term storage group was 14.5 days (7.4 - 27.5), long term storage group was 14.7 days(7.4 - 28.3)
Proportion of Patients Who Suffer at Least One Febrile Non-haemolytic Transfusion Reaction in ICU
Proportion of patients who suffer at least one febrile non-haemolytic transfusion reaction in ICU
Time frame: While in ICU-Median duration in ICU - short term storage group was 4.2 days (2.0 - 9.3), long term storage group was 4.2 days (1.9 - 9.4)
EuroQol-5Dimension 5 Level (EQ-5D-5L) Score at Day 180 Post Randomisation
EuroQol-5Dimension 5 level (EQ-5D-5L) score at day 180 post randomisation - not reported yet
Time frame: Day 180
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Bendigo, Australia
Logan Hospital
Brisbane, Australia
Mater Adult Hospital
Brisbane, Australia
Mater Private Hospital
Brisbane, Australia
Princess Alexandra Hospital
Brisbane, Australia
...and 50 more locations